Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.4 (
trypsin
)
42,187
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Post-translational modifications are used by cells to control the functions of proteins.
Phosducin-like protein
(
PhLP
) is a regulator of G-protein signaling that is post-translationally modified via phosphorylation. Phosphorylation of
PhLP
initiates its degradation by the 26S proteasome in serum-stimulated cells. In this report, we show that
PhLP
is phosphorylated in serum-stimulated Chinese hamster ovary (CHO) cells. Through the use of tandem mass spectrometry (MS/MS), the specific amino acids phosphorylated can be identified. A
PhLP
-myc-His construct was purified and phosphorylated by serum-stimulated CHO extract. The resulting protein was digested with
trypsin
and the peptides were identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Automated collison-induced dissociation data acquisition was compared with LC-MS/MS of manually chosen parents. In general, LC-MS/MS is superior for parent ions chosen manually, with the notable exception that automated fragmentation employs dynamic collision energy, which can result in higher quality collison-induced dissociation. Using the LC-MS/MS methods, four phosphorylation sites on
PhLP
were positively identified.
...
PMID:Identification of phosphorylation sites on phosducin-like protein by QTOF mass spectrometry. 1558 22